Please ensure Javascript is enabled for purposes of website accessibility

CAR-T therapy

Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake
Feb 9, 2026

Lilly bets on next-generation cell therapy with $2.4 billion deal for Orna

Eli Lilly agreed to buy Orna Therapeutics for up to $2.4 billion, gaining in vivo CAR-T and circular RNA technology platform.

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.